Drugs that contain Fluticasone Furoate
1. List of Arnuity Ellipta drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9333310 | GLAXOSMITHKLINE | Medicament dispenser |
Oct, 2027
(4 years from now) | |
| US8113199 | GLAXOSMITHKLINE | Counter for use with a medicament dispenser |
Oct, 2027
(4 years from now) | |
| US8161968 | GLAXOSMITHKLINE | Medicament dispenser |
Feb, 2028
(4 years from now) | |
| US8201556 | GLAXOSMITHKLINE | Medicament dispenser |
Feb, 2029
(5 years from now) | |
| US8534281 | GLAXOSMITHKLINE | Manifold for use in medicament dispenser |
Mar, 2030
(6 years from now) | |
| US8746242 | GLAXOSMITHKLINE | Medicament dispenser |
Oct, 2030
(7 years from now) | |
Market Authorisation Date: 20 August, 2014
Treatment: NA
Dosage: POWDER;INHALATION
ARNUITY ELLIPTA family patents
10
United States
10
United Kingdom
7
European Union
6
Japan
5
South Africa
5
Denmark
5
Australia
5
Brazil
5
Spain
5
Poland
5
China
5
Canada
4
Mexico
4
Portugal
4
Cyprus
4
Korea, Republic of
3
Israel
3
Hong Kong
3
Hungary
3
Norway
3
New Zealand
2
Singapore
1
Austria
1
Germany
1
Argentina
1
Malaysia
1
Taiwan, Province of China
2. List of Flonase Sensimist Allergy Relief drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9320862 | GLAXOSMITHKLINE CONS | Fluid dispensing device |
Nov, 2024
(1 year, 7 months from now) | |
| US8062264 | GLAXOSMITHKLINE CONS | Fluid dispensing device |
Apr, 2026
(3 years from now) | |
| US8752543 | GLAXOSMITHKLINE CONS | Fluid dispensing device |
Apr, 2026
(3 years from now) | |
| US8347879 | GLAXOSMITHKLINE CONS | Fluid dispensing device |
Jul, 2028
(5 years from now) | |
| US8147461 | GLAXOSMITHKLINE CONS | Fluid dispensing device |
Oct, 2028
(5 years from now) | |
Market Authorisation Date: 02 August, 2016
Treatment: NA
Dosage: SPRAY, METERED;NASAL
FLONASE SENSIMIST ALLERGY RELIEF family patents
10
United Kingdom
9
European Union
8
Australia
8
United States
8
China
8
Japan
5
South Africa
5
Brazil
5
Canada
4
Denmark
4
Austria
4
Hong Kong
4
Portugal
4
Cyprus
4
Spain
4
Poland
4
New Zealand
3
Israel
3
Mexico
3
Norway
3
Germany
3
Korea, Republic of
2
Singapore
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic